Oct 15, 2024
TransMedics to Report Third Quarter 2024 Financial Results on October 28, 2024
Sep 27, 2024
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Aug 21, 2024
TransMedics to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
Aug 20, 2024
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Jul 29, 2024
TransMedics to Present at the Canaccord Genuity 44th Annual Growth Conference
Jul 18, 2024
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Jul 17, 2024
TransMedics to Report Second Quarter 2024 Financial Results on July 31, 2024
May 17, 2024
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Apr 30, 2024
TransMedics Reports First Quarter 2024 Financial Results
Apr 16, 2024
TransMedics to Report First Quarter 2024 Financial Results on April 30, 2024
Apr 08, 2024
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Feb 28, 2024
TransMedics to Present at Upcoming March Investor Conferences
Feb 28, 2024
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Feb 26, 2024
TransMedics Reports Fourth Quarter and Full Year 2023 Financial Results
Feb 12, 2024
TransMedics to Report Fourth Quarter and Full Year 2023 Financial Results on February 26, 2024
Feb 16, 2021
TransMedics to Report Fourth Quarter and Full Year 2020 Financial Results on March 2, 2021
Dec 24, 2020
TransMedics to Present at the 39th Annual J.P. Morgan Healthcare Conference
Dec 23, 2020
TransMedics Appoints Merilee Raines to Board of Directors
Oct 29, 2020
TransMedics to Participate in Upcoming Virtual Investor Conferences